US Stock MarketDetailed Quotes

IPSC Century Therapeutics

Watchlist
  • 0.909
  • +0.004+0.45%
Close Jan 17 16:00 ET
  • 0.909
  • 0.0000.00%
Post 16:02 ET
77.32MMarket Cap-0.50P/E (TTM)

Century Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-107.58%-28.33M
-41.98%-27.33M
-3.52%-30.25M
-728.72%-88.35M
-14.51%-26.23M
43.69%-13.65M
24.68%-19.25M
-133.68%-29.22M
115.79%14.05M
5.93%-22.91M
Net income from continuing operations
4.57%-31.22M
6.26%-31.21M
10.24%-28.06M
-4.38%-136.67M
-24.35%-39.4M
-6.41%-32.72M
-7.43%-33.29M
16.66%-31.26M
-36.64%-130.93M
-12.37%-31.68M
Depreciation and amortization
-1.55%3.3M
7.05%3.46M
10.94%3.23M
54.55%13.04M
25.16%3.55M
20.76%3.35M
93.88%3.23M
150.69%2.91M
125.19%8.44M
170.03%2.84M
Other non cash items
185.13%372K
-212.58%-2.46M
326.10%1.54M
-157.10%-1.1M
30.94%804K
-181.23%-437K
-253.11%-787K
-358.33%-682K
59.64%1.93M
86.06%614K
Change In working capital
-122.78%-2.78M
-82.56%713K
-127.40%-9.05M
-92.43%9.38M
-212.35%-2.91M
2,849.15%12.18M
753.65%4.09M
-103.30%-3.98M
4,531.36%123.95M
213.68%2.59M
-Change in prepaid assets
-206.66%-721K
1,278.70%1.27M
-2,021.88%-3.4M
-35.12%667K
-81.80%259K
206.62%676K
86.40%-108K
-115.49%-160K
132.31%1.03M
860.96%1.42M
-Change in payables and accrued expense
-78.70%1.48M
-249.54%-2.12M
57.63%-2.61M
-271.96%-3.09M
-952.69%-5.27M
184.87%6.93M
1,689.89%1.42M
-130.45%-6.16M
-132.12%-831K
-145.38%-501K
-Change in other current liabilities
-157.98%-2.74M
-19.26%2.33M
-156.90%-2.19M
162.82%13.82M
14.92%2.37M
560.70%4.72M
9.50%2.88M
2,627.63%3.84M
12,924.39%5.26M
1,051.15%2.06M
-Change in other working capital
-434.46%-791K
-677.78%-770K
43.00%-855K
-101.70%-2.02M
32.15%-268K
92.95%-148K
92.20%-99K
-101.23%-1.5M
15,013.52%118.49M
-413.49%-395K
Cash from discontinued investing activities
Operating cash flow
-107.58%-28.33M
-41.98%-27.33M
-3.52%-30.25M
-728.72%-88.35M
-14.51%-26.23M
43.69%-13.65M
24.68%-19.25M
-133.68%-29.22M
115.79%14.05M
5.93%-22.91M
Investing cash flow
Cash flow from continuing investing activities
829.55%39.2M
-585.57%-33.86M
-63.17%11.54M
565.66%61.13M
535.36%18.6M
-81.39%4.22M
-44.29%6.97M
171.16%31.34M
95.60%-13.13M
79.26%-4.27M
Net PPE purchase and sale
125.27%825K
94.11%-265K
89.20%-539K
55.12%-13.74M
84.37%-980K
66.72%-3.27M
56.97%-4.5M
-22.72%-4.99M
31.95%-30.6M
62.51%-6.27M
Net business purchase and sale
--0
----
----
----
----
--0
----
----
----
----
Net investment purchase and sale
412.88%38.37M
-309.09%-23.99M
-66.75%12.08M
328.40%74.87M
881.60%19.58M
-76.96%7.48M
-50.06%11.47M
190.89%36.33M
106.90%17.48M
151.40%2M
Cash from discontinued investing activities
Investing cash flow
829.55%39.2M
-585.57%-33.86M
-63.17%11.54M
565.66%61.13M
535.36%18.6M
-81.39%4.22M
-44.29%6.97M
171.16%31.34M
95.60%-13.13M
79.26%-4.27M
Financing cash flow
Cash flow from continuing financing activities
-9.00%273K
660.41%56.7M
3,961.38%18.2M
-135.81%-9.73M
-474.74%-356K
118.98%300K
-21,177.08%-10.12M
-98.33%448K
-93.50%27.16M
-10.38%95K
Net issuance payments of debt
--0
----
----
---10.24M
--0
--0
----
----
--0
--0
Net common stock issuance
-9.00%273K
45,623.39%56.7M
3,961.38%18.2M
-98.10%516K
-474.74%-356K
118.98%300K
158.33%124K
-98.33%448K
-87.75%27.16M
14.46%95K
Cash from discontinued financing activities
Financing cash flow
-9.00%273K
660.41%56.7M
3,961.38%18.2M
-135.81%-9.73M
-474.74%-356K
118.98%300K
-21,177.08%-10.12M
-98.33%448K
-93.50%27.16M
-10.38%95K
Net cash flow
Beginning cash position
-33.31%44.29M
-45.06%48.79M
-42.83%49.3M
48.28%86.24M
-49.45%57.29M
-42.13%66.42M
-30.48%88.81M
48.28%86.24M
109.76%58.16M
10.02%113.33M
Current changes in cash
221.99%11.14M
79.91%-4.5M
-119.95%-512K
-231.55%-36.94M
70.53%-7.98M
-535.49%-9.13M
-72.39%-22.39M
-96.31%2.57M
-7.73%28.08M
39.61%-27.09M
End cash Position
-3.24%55.43M
-33.31%44.29M
-45.06%48.79M
-42.83%49.3M
-42.83%49.3M
-49.45%57.29M
-42.13%66.42M
-30.48%88.81M
48.28%86.24M
48.28%86.24M
Free cash flow
-62.75%-27.53M
-16.20%-27.6M
10.01%-30.79M
-516.75%-102.08M
6.74%-27.21M
50.33%-16.91M
34.05%-23.75M
-141.37%-34.21M
87.65%-16.55M
28.97%-29.18M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -107.58%-28.33M -41.98%-27.33M -3.52%-30.25M -728.72%-88.35M -14.51%-26.23M 43.69%-13.65M 24.68%-19.25M -133.68%-29.22M 115.79%14.05M 5.93%-22.91M
Net income from continuing operations 4.57%-31.22M 6.26%-31.21M 10.24%-28.06M -4.38%-136.67M -24.35%-39.4M -6.41%-32.72M -7.43%-33.29M 16.66%-31.26M -36.64%-130.93M -12.37%-31.68M
Depreciation and amortization -1.55%3.3M 7.05%3.46M 10.94%3.23M 54.55%13.04M 25.16%3.55M 20.76%3.35M 93.88%3.23M 150.69%2.91M 125.19%8.44M 170.03%2.84M
Other non cash items 185.13%372K -212.58%-2.46M 326.10%1.54M -157.10%-1.1M 30.94%804K -181.23%-437K -253.11%-787K -358.33%-682K 59.64%1.93M 86.06%614K
Change In working capital -122.78%-2.78M -82.56%713K -127.40%-9.05M -92.43%9.38M -212.35%-2.91M 2,849.15%12.18M 753.65%4.09M -103.30%-3.98M 4,531.36%123.95M 213.68%2.59M
-Change in prepaid assets -206.66%-721K 1,278.70%1.27M -2,021.88%-3.4M -35.12%667K -81.80%259K 206.62%676K 86.40%-108K -115.49%-160K 132.31%1.03M 860.96%1.42M
-Change in payables and accrued expense -78.70%1.48M -249.54%-2.12M 57.63%-2.61M -271.96%-3.09M -952.69%-5.27M 184.87%6.93M 1,689.89%1.42M -130.45%-6.16M -132.12%-831K -145.38%-501K
-Change in other current liabilities -157.98%-2.74M -19.26%2.33M -156.90%-2.19M 162.82%13.82M 14.92%2.37M 560.70%4.72M 9.50%2.88M 2,627.63%3.84M 12,924.39%5.26M 1,051.15%2.06M
-Change in other working capital -434.46%-791K -677.78%-770K 43.00%-855K -101.70%-2.02M 32.15%-268K 92.95%-148K 92.20%-99K -101.23%-1.5M 15,013.52%118.49M -413.49%-395K
Cash from discontinued investing activities
Operating cash flow -107.58%-28.33M -41.98%-27.33M -3.52%-30.25M -728.72%-88.35M -14.51%-26.23M 43.69%-13.65M 24.68%-19.25M -133.68%-29.22M 115.79%14.05M 5.93%-22.91M
Investing cash flow
Cash flow from continuing investing activities 829.55%39.2M -585.57%-33.86M -63.17%11.54M 565.66%61.13M 535.36%18.6M -81.39%4.22M -44.29%6.97M 171.16%31.34M 95.60%-13.13M 79.26%-4.27M
Net PPE purchase and sale 125.27%825K 94.11%-265K 89.20%-539K 55.12%-13.74M 84.37%-980K 66.72%-3.27M 56.97%-4.5M -22.72%-4.99M 31.95%-30.6M 62.51%-6.27M
Net business purchase and sale --0 ---- ---- ---- ---- --0 ---- ---- ---- ----
Net investment purchase and sale 412.88%38.37M -309.09%-23.99M -66.75%12.08M 328.40%74.87M 881.60%19.58M -76.96%7.48M -50.06%11.47M 190.89%36.33M 106.90%17.48M 151.40%2M
Cash from discontinued investing activities
Investing cash flow 829.55%39.2M -585.57%-33.86M -63.17%11.54M 565.66%61.13M 535.36%18.6M -81.39%4.22M -44.29%6.97M 171.16%31.34M 95.60%-13.13M 79.26%-4.27M
Financing cash flow
Cash flow from continuing financing activities -9.00%273K 660.41%56.7M 3,961.38%18.2M -135.81%-9.73M -474.74%-356K 118.98%300K -21,177.08%-10.12M -98.33%448K -93.50%27.16M -10.38%95K
Net issuance payments of debt --0 ---- ---- ---10.24M --0 --0 ---- ---- --0 --0
Net common stock issuance -9.00%273K 45,623.39%56.7M 3,961.38%18.2M -98.10%516K -474.74%-356K 118.98%300K 158.33%124K -98.33%448K -87.75%27.16M 14.46%95K
Cash from discontinued financing activities
Financing cash flow -9.00%273K 660.41%56.7M 3,961.38%18.2M -135.81%-9.73M -474.74%-356K 118.98%300K -21,177.08%-10.12M -98.33%448K -93.50%27.16M -10.38%95K
Net cash flow
Beginning cash position -33.31%44.29M -45.06%48.79M -42.83%49.3M 48.28%86.24M -49.45%57.29M -42.13%66.42M -30.48%88.81M 48.28%86.24M 109.76%58.16M 10.02%113.33M
Current changes in cash 221.99%11.14M 79.91%-4.5M -119.95%-512K -231.55%-36.94M 70.53%-7.98M -535.49%-9.13M -72.39%-22.39M -96.31%2.57M -7.73%28.08M 39.61%-27.09M
End cash Position -3.24%55.43M -33.31%44.29M -45.06%48.79M -42.83%49.3M -42.83%49.3M -49.45%57.29M -42.13%66.42M -30.48%88.81M 48.28%86.24M 48.28%86.24M
Free cash flow -62.75%-27.53M -16.20%-27.6M 10.01%-30.79M -516.75%-102.08M 6.74%-27.21M 50.33%-16.91M 34.05%-23.75M -141.37%-34.21M 87.65%-16.55M 28.97%-29.18M
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion -- -- -- -- -- --
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.